H.R. 8855
Referred to CommitteeSickle Cell Disease Treatment Centers Act of 2022
Latest Action
Referred to the Subcommittee on Health.
9/16/2022 • House
Summary
Sickle Cell Disease Treatment Centers Act of 2022
This bill directs the Department of Health and Human Services to award grants for establishing sickle cell disease treatment centers that operate using a hub-and-spoke framework to provide integrated, longitudinal health care for patients with the disease and individuals with sickle cell trait. Grant recipients must be networks comprised of (1) a hospital, clinic, or university health center; (2) at least one federally qualified health center or other health care organization that incorporates community health workers into the care team; and (3) at least one community-based organization.
Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.
Introduced in House • 9/15/2022
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (5)
Party Breakdown
Sponsor
Cosponsors (4)
Bill Journey
Originated in the House
Introduced
September 15, 2022
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law